Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Oral neuraminidase inhibitor advances to phase II/III

Dec. 19, 1997

Daiichi's Floxin receives FDA approval

Dec. 18, 1997

Pentose receives U.S. and European patent allowances for Papirine compounds

Dec. 18, 1997

Potent, broad-spectrum carbapenem discovered at Fujisawa

Dec. 18, 1997

Millennium/Pfizer antifungal collaboration expanded

Dec. 17, 1997

Faropenem data presented at Japanese congress

Dec. 16, 1997

New AmBisome data reported

Dec. 16, 1997

TAP acquires North American rights to Meiact

Dec. 15, 1997

Preclinical profile of optically active triazole antifungal agent presented by Takeda

Dec. 12, 1997

Abelcet continues to demonstrate effectiveness

Dec. 12, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...